We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Rapid Malaria Diagnostic Test Evaluated in Asia

By LabMedica International staff writers
Posted on 03 Jan 2013
Rapid diagnostic tests (RDT) for malaria have been brought into field operations to supplement and in some cases replace the gold standard of light microscopy. More...


Although attempts have been made to augment or even replace microscopic diagnosis of malaria with enzyme-linked immunosorbent assays (ELISA), real time, and conventional polymerase chain reactions (PCR), these are not feasible in the field.

Scientists at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B; Dhaka, Bangladesh) collected whole blood samples from 372 febrile patients referred for malaria diagnosis by clinicians from May 2009 to December 2010. The samples were assayed by a newly available RDT and were compared to microscopy adjusted with nested PCR as the gold standard. DNA extraction for the PCR was prepared using QiaAmp blood mini-kit (Qiagen; Hilden, Germany) from preserved whole blood. Other PCR reagents were obtained from New England BioLabs Inc.; Ipswich, MA, USA).

The RDT device evaluated was the Onsite (Pf/Pan) RDT produced by CTK Biotech Inc. (San Diego, CA, USA) which has the ability to detect Pan-specific lactate dehydrogenase (pLDH) and Plasmodium falciparum specific histidine-rich protein 2 (HRP-2). Of these 372 patients, 229 (61.6%) tested positive for malaria infection detected by microscopy and nested PCR. The OnSite (Pf/Pan) RDT was 94.2% sensitive and 99.5% specific for P. falciparum diagnosis and 97.3% sensitive and 98.7% specific for P. vivax diagnosis. Sensitivity varied with differential parasite count for both malaria species. The highest sensitivity was observed in febrile patients with parasitemias that ranged from 501 to 1,000 parasites/µL regardless of the Plasmodium species.

The authors concluded that the OnSite (Pf/Pan) RDT, a lateral flow chromatographic immunoassay, performed satisfactorily in standard laboratory conditions. It can be utilized for diagnosis of symptomatic malaria as well as to discriminate falciparum malaria infection from vivax malaria in endemic areas and during outbreaks. However, a field evaluation is required to assess its applicability for routine diagnosis in resource-limited settings where the practicability of microscopy is limited. The study was published on December 12, 2012, in the Malaria Journal.

Related Links:
International Centre for Diarrheal Disease Research Bangladesh
Qiagen
New England BioLabs Inc.




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.